Background Tobacco smoking is responsible for over 90% of lung cancer cases, and yet the
precise molecular alterations induced by smoking in lung that develop into cancer and …

Background The Food and Drug Administration can set standards that reduce the nicotine
content of cigarettes. Methods We conducted a double-blind, parallel, randomized clinical trial …

Aims To examine the effects of reduced nicotine cigarettes on smoking behavior, toxicant
exposure, dependence and abstinence. Design Randomized, parallel arm, semi‐blinded study…

We quantified urinary levels of two metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
(NNK) in people who had stopped smoking: 4-(…

Introduction: Electronic cigarettes (e-cigarettes) are rapidly increasing in popularity but little
information is available on their potential toxic or carcinogenic effects. Methods: Twenty-eight …

Background Environmental tobacco smoke has been classified by the Environmental Protection
Agency as a carcinogen causally associated with lung cancer in adults, but there have …

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides (sum of which is
denoted as total NNAL) are metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (…

Smokers or people undergoing nicotine replacement therapy excrete approximately 10% of
the nicotine dose as 4-oxo-4-(3-pyridyl)butanoic acid (keto acid) and 4-hydroxy-4-(3-pyridyl)…

Importance The optimal temporal approach for reducing nicotine to minimally or nonaddictive
levels in all cigarettes sold in the United States has not been determined. Objectives To …

Nicotine metabolism influences smoking behavior and differences in metabolism probably
contribute to ethnic variability in lung cancer risk. We report here on the proportion of nicotine …